You are here

Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants.

Pubmed ID: 
31194112
Year: 
2019
Month: 
Jun
Volume: 
4
Issue: 
6
Citation: 
McBride L, Houlihan C, Quinlan C, Messazos B, Stark Z, Crosthwaite A. Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants. Kidney international reports 4 (6) : 888 - 892(2019) PubMed